ATF6 Activation Reduces Amyloidogenic Transthyretin Secretion through Increased Interactions with Endoplasmic Reticulum Proteostasis Factors.
ATF6 Activation Reduces Amyloidogenic Transthyretin Secretion through Increased Interactions with Endoplasmic Reticulum Proteostasis Factors.
复制标题
DOI:
10.3390/cells11101661
复制
发表时间:
2022-05-17
期刊:
影响因子:
6
通讯作者:
Wiseman, R. Luke
中科院分区:
文献类型:
--
作者:
Mesgarzadeh, Jaleh S.;Romine, Isabelle C.;Smith-Cohen, Ethan M.;Grandjean, Julia M. D.;Kelly, Jeffery W.;Genereux, Joseph C.;Wiseman, R. Luke
关键词:
The extracellular aggregation of destabilized transthyretin (TTR) variants is implicated in the onset and pathogenesis of familial TTR-related amyloid diseases. One strategy to reduce the toxic, extracellular aggregation of TTR is to decrease the population of aggregation-prone proteins secreted from mammalian cells. The stress-independent activation of the unfolded protein response (UPR)-associated transcription factor ATF6 preferentially decreases the secretion and subsequent aggregation of destabilized, aggregation-prone TTR variants. However, the mechanism of this reduced secretion was previously undefined. Here, we implement a mass-spectrometry-based interactomics approach to identify endoplasmic reticulum (ER) proteostasis factors involved in ATF6-dependent reductions in destabilized TTR secretion. We show that ATF6 activation reduces amyloidogenic TTR secretion and subsequent aggregation through a mechanism involving ER retention that is mediated by increased interactions with ATF6-regulated ER proteostasis factors including BiP and PDIA4. Intriguingly, the PDIA4-dependent retention of TTR is independent of both the single TTR cysteine residue and the redox activity of PDIA4, indicating that PDIA4 retains destabilized TTR in the ER through a redox-independent mechanism. Our results define a mechanistic basis to explain the ATF6 activation-dependent reduction in destabilized, amyloidogenic TTR secretion that could be therapeutically accessed to improve treatments of TTR-related amyloid diseases.
登录
查看更多内容
影响因子:
3.7
作者:
Coelho T;Merlini G;Bulawa CE;Fleming JA;Judge DP;Kelly JW;Maurer MS;Planté-Bordeneuve V;Labaudinière R;Mundayat R;Riley S;Lombardo I;Huertas P
通讯作者:
Huertas P
DOI:
10.1083/jcb.202112104
发表时间:
2022-04-04
期刊:
The Journal of cell biology
影响因子:
--
作者:
Mesgarzadeh JS;Buxbaum JN;Wiseman RL
通讯作者:
Wiseman RL
影响因子:
8.6
作者:
Plate, Lars;Rius, Bibiana;Wiseman, R. Luke
通讯作者:
Wiseman, R. Luke
影响因子:
15
作者:
Choi, Sungwook;Ong, Derrick Sek Tong;Kelly, Jeffery W.
通讯作者:
Kelly, Jeffery W.
DOI:
10.1007/s00018-009-0109-0
发表时间:
2009-10
期刊:
Cellular and molecular life sciences : CMLS
影响因子:
--
作者:
Buxbaum JN;Reixach N
通讯作者:
Reixach N